An Observational Study of Patients With HER2-Positive Metastatic or Locally Advanced Breast Cancer Treated With Herceptin (Trastuzumab) in 1st Line and Without Progression For 3 Years
Clinical trial NCT01480674 · COMPLETED
Trial details
- NCT number
- NCT01480674
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2011-03-28
- Primary completion
- 2012-11-16
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.